Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

by Rossi, L, Laas, E, Mallon, P, Vincent-Salomon, A, Guinebretiere, J-M, Lerebours, F, Rouzier, R, Pierga, J-Y, Reyal, F
Published 2015

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

by Baulies, S, Belin, L, Mallon, P, Senechal, C, Pierga, J-Y, Cottu, P, Sablin, M-P, Sastre, X, Asselain, B, Rouzier, R, Reyal, F
Published 2015

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models

by Laas, E, Mallon, P, Delomenie, M, Gardeux, V, Pierga, J-Y, Cottu, P, Lerebours, F, Stevens, D, Rouzier, R, Reyal, F
Published 2015

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

by Mouttet, D., Laé, M., Caly, M., Gentien, D., Carpentier, S., Peyro-Saint-Paul, H., Vincent-Salomon, A., Rouzier, R., Sigal-Zafrani, B., Sastre-Garau, X., Reyal, F.
Published 2016

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

by Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Published 2014

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival

by Houvenaeghel, G, Sabatier, R, Reyal, F, Classe, J M, Giard, S, Charitansky, H, Rouzier, R, Faure, C, Garbay, J R, Daraï, E, Hudry, D, Gimbergues, P, Villet, R, Lambaudie, E
Published 2016